// App-Quantinova.ai

TCT-459 : Real-world experience of biolimus A9- and everolimus-eluting stents in all-comer Korean registries: Patient-oriented and stent-related 3-year outcomes from the multicenter prospective Biolimus-Korea-3000 registry and Excellent-Prime registry

Researchers

Presenter

  • Ch Kim

Principal Investigators

  • Ji-Hyun Jung

  • Jung-kyu Han

  • Han-Mo Yang

  • Kyung Woo KW Park

  • Hae-Young Lee

  • Hyun-Jae Kang

  • Bon-Kwon Koo

  • Hyo-Soo Kim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Umirolimus

  • Everolimus

  • Biolimus A9

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved